COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure

NCT01786512 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

544

Enrollment

INDUSTRY

Sponsor class

Conditions

Modified Release Oral Formulation
Left Ventricular Systolic Dysfunction
Chronic Heart Failure
History of Chronic Heart Failure
Left Ventricular Ejection Fraction
Pharmacokinetics
Echocardiogram

Interventions

DRUG: Omecamtiv Mecarbil Matrix F1 Formulation
DRUG: Omecamtiv Mecarbil Matrix F2 Formulation
DRUG: Placebo
DRUG: Omecamtiv Mecarbil Swellable Core Technology F2

Sponsor

Cytokinetics